Europe — EMA
Obizur (Susoctocog Alfa)
Susoctocog alfa, the active ingredient in Obizur, is a recombinant factor VIII (rFVIII) presented as a intravenous solution for intravenous use.
Request sourcing
What is Susoctocog Alfa?
Susoctocog alfa, the active ingredient in Obizur, is a recombinant factor VIII (rFVIII) presented as a intravenous solution for intravenous use. It replaces deficient clotting factor VIII in patients with hemophilia A, helping to control and prevent bleeding episodes. GNH USA supplies Obizur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
GNH USA supplies Obizur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.
What is Susoctocog Alfa used for?
Obizur is a recombinant factor VIII product that acts on the coagulation cascade in hemophilia A patients. - Hemophilia A (severe): Provides factor VIII replacement to achieve hemostasis during bleeding episodes. - Hemophilia A (moderate) : ... ... ... - ... ... ... ... ... ... ... … ... ...
